Common Contracts
11 similar At Market Issuance Sales Agreement contracts by Novavax Inc, American Superconductor Corp /De/, Anworth Mortgage Asset Corp, others
SOLIGENIX, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • August 11th, 2017 • Soligenix, Inc. • Pharmaceutical preparations • New York
Standard Contracts
MONMOUTH REAL ESTATE INVESTMENT CORPORATION (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • June 29th, 2017 • Monmouth Real Estate Investment Corp • Real estate investment trusts • New York
PLUG POWER INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 3rd, 2017 • Plug Power Inc • Electrical industrial apparatus • New York
Plug Power Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”) as follows:
AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • February 27th, 2017 • Novavax Inc • Biological products, (no disgnostic substances) • New York
VIEWRAY, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • January 30th, 2017 • ViewRay, Inc. • Electromedical & electrotherapeutic apparatus • New York
ViewRay, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”) as follows:
AMERICAN SUPERCONDUCTOR CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • January 27th, 2017 • American Superconductor Corp /De/ • Motors & generators • New York
American Superconductor Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with FBR Capital Markets & Co. (“FBR”), as follows:
AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • December 30th, 2016 • Novavax Inc • Biological products, (no disgnostic substances) • New York
Novavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co., a Delaware limited liability company (“FBR”), as follows:
ENPHASE ENERGY, INC. Common Stock (par value $0.00001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • December 23rd, 2016 • Enphase Energy, Inc. • Semiconductors & related devices • New York
Enphase Energy, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”), as follows:
BIONDVAX PHARMACEUTICALS LTD. American Depositary Shares (each representing 40 fully paid Ordinary Shares) AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • November 4th, 2016 • BiondVax Pharmaceuticals Ltd. • Biological products, (no disgnostic substances) • New York
ANWORTH MORTGAGE ASSET CORPORATION Common Stock (par value $0.01 per share) (par value $0.01 per share) (par value $0.01 per share) AT MARKET ISSUANCE SALES AGREEMENTAt Market Issuance Sales Agreement • August 10th, 2016 • Anworth Mortgage Asset Corp • Real estate investment trusts • New York
ANWORTH MORTGAGE ASSET CORPORATION, a Maryland corporation (the “Company”), and ANWORTH MANAGEMENT LLC, a Delaware limited liability company (the “Manager”), confirm their agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”), as follows:
MANNKIND CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 26th, 2016 • Mannkind Corp • Pharmaceutical preparations • New York
MannKind Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”), as follows:
